Do leukotrienes increase cell viability in human intestinal epithelial cells?

Advances in Experimental Medicine and Biology

Volumn 507, Issue , 2002, Pages 193-198

  Öhd, John F ^a   Wikström, Katarina ^a   Sjölander, Anita ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; G PROTEIN COUPLED RECEPTOR; LEUKOTRIENE B4; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE E4; PROSTAGLANDIN E2; PROTEIN BCL 2; LEUKOTRIENE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; N-(2-CYCLOHEXYLOXY-4-NITROPHENYL)METHANESULFONAMIDE; NITROBENZENE DERIVATIVE; PROSTAGLANDIN SYNTHASE INHIBITOR; SULFONAMIDE;

CELL DEATH; CELL MEMBRANE; CELL VIABILITY; COLON CANCER; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INFLAMMATORY CELL; INTESTINE EPITHELIUM CELL; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; SIGNAL TRANSDUCTION; ARTICLE; CELL LINE; CELL SURVIVAL; CYTOLOGY; DRUG EFFECT; INTESTINE MUCOSA; PHYSIOLOGY;

CELL LINE; CELL SURVIVAL; CYCLOOXYGENASE INHIBITORS; HUMANS; INTESTINAL MUCOSA; LEUKOTRIENES; NITROBENZENES; SULFONAMIDES;

EID: 0142226856     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-0193-0_30     Document Type: Conference Paper

References (21)

1. R. L. Shattuck-Brandt, G. W. Varilek, A. Radhika, F. Yang, et al., Cyclooxygenase 2 expression is increased in the stroma of colon carcinomas from IL-10(-/-) mice, Gastroenterology 118:337 (2000).
2. H. Sheng, J. Shao, S. C. Kirkland, P. Isakson, et al., Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2, J. Clin. Invest. 99:2254 (1997).
3. S. M. Powell, N. Zilz, Y. Beazer-Barclay, T. M. Bryan, et al., APC mutations occur early during colorectal tumorigenesis, Nature 359:235 (1992).
4. P. J. Morin, A. B. Sparks, V. Korinek, N. Barker, et al., Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC, Science 275:1787 (1997).
5. S. Munemitsu, I. Albert, B. Souza, B. Rubinfeld, et al., Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein, Proc. Natl. Acad. Sci. U S A 92: 3046 (1995).
6. W. E. Smalley, and R. N. DuBois, Colorectal cancer and nonsteroidal anti-inflammatory drugs, Adv. Pharmacol. 39:1 (1997).
7. J. Hendel, and O. H. Nielsen, Expression of cyclooxygenase-2 mRNA in active inflammatory bowel disease, Am. J. Gastroenterol. 92:1170 (1997).
8. H. Sheng, J. Shao, J. D. Morrow, R. D. Beauchamp, et al., Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells, Cancer Res. 58:362 (1998).
9. A. Ekbom, C. Helmick, M. Zack, and H. O. Adami, Ulcerative colitis and colorectal cancer. A population-based study, N. Engl. J. Med. 323:1228 (1990).
10. B. Samuelsson, S. E. Dahlen, J. A. Lindgren, C. A. Rouzer, et al., Leukotrienes and lipoxins: structures, biosynthesis, and biological effects, Science 237:1171 (1987).
11. 2+, J. Biol. Chem. 265: 20976 (1990).
12. K. R. Lynch, G. P. O'Neill, Q. Liu, D. S. Im, et al., Characterization of the human cysteinyl leukotriene CysLT1 receptor, Nature 399:789 (1999).
13. 4 that mediates chemotaxis, Nature 387:620 (1997).
14. i3-subunit in human epithelial cells, Biochem. Biophys. Res. Commun. 226:413 (1996).
15. D. M. Hammerbeck, and D. R. Brown, Presence of immunocytes and sulfidopeptide leukotrienes in the inflamed guinea pig distal colon, Inflammation 20:413 (1996).
16. C. H. Chiu, M. F. McEntee, and J. Whelan, Sulindac causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis, Cancer Res. 57:4267 (1997).
17. C. N. Serhan, J. Z. Haeggstrom, and C. C. Leslie, Lipid mediator networks in cell signaling: update and impact of cytokines, Faseb J. 10:1147 (1996).
18. 4 induced vascular smooth muscle cell proliferation: a possible role in myointimal hyperplasia, Thromb. Haemost. 76:99 (1996).
19. T. A. Chan, P. J. Morin, B. Vogelstein, and K. W. Kinzler, Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis, Proc. Natl. Acad. Sci. U S A 95:681 (1998).
20. J. F. Öhd, K. Wikström, and A. Sjölander, Leukotriene induced cell survival in human epithelial intestine cells, Mol. Biol. Cell 188a (1999).
21. M. F. McEntee, C. H. Chiu, and J. Whelan, Relationship of beta-catenin and Bcl-2 expression to sulindac-induced regression of intestinal tumors in Min mice, Carcinogenesis 20: 635 (1999).